Capital Flow Monitor · Sponsors · CIK 2134488
Dimension Capital III, L.P.
632 Broadway, New York, NY, 10012 · 917-450-1156
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
$750.0M
Sold
$0
% sold
0.0%
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | D ·current | 506(b) | $750.0M | $0 | 0.0% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A Dimension Capital III GP, L.P. — Director, New York, NY
- N/A Dimension Capital III GP, LLC — Director, New York, NY
- Adam Goulburn — Executive Officer, New York, NY
- Zavain Dar — Executive Officer, New York, NY
-
Nan Li — Executive Officer, New York, NY
2 other raises
- Odyssey Therapeutics, Inc. $214.0M of $214.0M · 100.0%
- Fiveonefour Labs Inc. $10.8M of $10.8M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.